Stay updated with breaking news from Source Medical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Real-world data from a systemic review of treatment patterns in the United States showed that the majority of patients with hepatocellular carcinoma administered atezolizumab and bevacizumab in the frontline setting discontinued treatment within 12 months, indicating the need for additional research on the effectiveness of this regimen for patients with high-risk disease.
/PRNewswire/ -- The "Healthcare Distribution: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market...
DUBLIN, July 7, 2023 /PRNewswire/ -- The "Healthcare Distribution: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Healthcare Distribution
A federal lawsuit was filed this week against more than 30 drug makers and distributors blaming them for "corporate greed" and fueling the opioid crisis.
NEW TAIPEI CITY, Taiwan, Nov. 28, 2022 /PRNewswire/ -- Medeologix, a Taiwan MedTech CDMO company announces its successful acquisition of three pre...